Latest Asia Pacific News

ClearVue Technologies has inked a five-year exclusive manufacturing and distribution agreement with New Zealand’s Viridian Glass, marking its strategic entry into the New Zealand market with solar-integrated glazing solutions.

Orthocell has secured regulatory approval to sell its nerve repair product Remplir™ in Hong Kong well ahead of schedule, expanding its footprint across key global markets. This milestone complements recent clearances in the US, Canada, and Asia, positioning the company for significant growth in a multi-billion-dollar market.

TZ Limited has secured its inaugural purchase order for data centre cabinet locking kits from Wesco Anixter, acting on behalf of Microsoft, marking a significant commercial milestone after a successful pilot phase.

Neuren Pharmaceuticals reports a robust 11% rise in DAYBUE™ US net sales for Q1 2025, alongside a 17% jump in royalty income, setting the stage for an anticipated European market entry in early 2026.

Excite Technology Services has raised $2.8 million through a placement to accelerate growth in cybersecurity services and training, including investment in its flagship Nangu Tactical Centre.

Reliance Worldwide Corporation updates on the financial impact of new US tariffs, outlining a multi-pronged mitigation strategy and revising its FY25 sales outlook amid market uncertainty.

HeraMED reports strong Q1 FY25 progress with 4,282 registered users on its HeraCARE platform, a new collaboration with Garmin Health, and advancing commercial deals in the US and Europe. Early clinical data suggests improved maternal outcomes and operational efficiencies.

Ava Risk Group reported a solid Q3 FY2025 with $6.5 million in sales orders and a key new contract with Telstra for subsea cable protection, setting the stage for accelerated growth in Q4.

TerraCom Limited reported resilient coal sales of 1.6 million tonnes in Q3 2025 despite severe weather disruptions at Blair Athol, while advancing its Moorlands Thermal Coal Project with Wintime Energy.

NoviqTech has advanced its blockchain-based sustainability solutions, pioneering real-world asset tokenisation and expanding its investor base through OTCQB trading in the US.

EOS is midway through a strategic turnaround, divesting non-core assets and strengthening its balance sheet while advancing cutting-edge counter-drone, high energy laser weapons, and space control technologies amid robust global demand.

Tissue Repair Limited reports progress in its Phase 3 clinical trials for TR987® despite enrollment delays caused by US regulatory disruptions, while TR Pro+® sales hit record highs and manufacturing scale-up advances.